Safety and pharmacokinetics of hyperimmune anti-human immunodeficiency virus (HIV) immunoglobulin administered to HIV-infected pregnant women and their newborns

Journal of Infectious Diseases

Volumn 175, Issue 2, 1997, Pages 283-291

  Lambert, J S ^a   Mofenson, L M ^a   Fletcher, C V ^a   Moye J , Jr ^a   Stiehm, E R ^a   Meyer III, W A ^a   Nemo, G J ^a   Mathieson, B J ^a   Hirsch, G ^a   Sapan, C V ^a   Cummins, L M ^a   Jimenez, E ^a   O'Neill, E ^a   Kovacs, A ^a   Stek, A ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; FETOMATERNAL TRANSFUSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ADMINISTRATION; PREGNANCY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VIRUS TRANSMISSION;

EID: 17344391461     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/175.2.283     Document Type: Article

References (35)